4
Changes in Ownership
Alkermes plc. Filed Acc 0001520262-26-000009
EVP R&D, Chief Medical Officer sold 9,000 shares at an average $33.93 ($305,385)
- EVP R&D, Chief Medical Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $19.34 | $96,700 | 66,740 | D |
| 2026-02-02 | Sale : show line 2 in the form 10b5-1 | −5,000 | $34.24 | $171,225 | 61,740 | D |
| 2026-02-02 | Sale : show line 3 in the form 10b5-1 | −4,000 | $33.54 | $134,160 | 57,740 | D |
| Open-market sales · 9,000 sh · avg $33.93 · $305,385 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-02 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Buy) | −5,000 | 26,356 | D |
Loading xslF345X05/form4.xml…